Literature DB >> 16437173

Probing the mechanism of hypoxia selectivity of copper bis(thiosemicarbazonato) complexes: DFT calculation of redox potentials and absolute acidities in solution.

Jason P Holland1, Jennifer C Green, Jonathan R Dilworth.   

Abstract

Density functional theory (DFT) calculations have been performed using the uB3LYP/6-31++G(d,p) model to calculate the solution phase one-electron reduction potentials (E(calc)) and absolute pKa values of a series of copper bis(thiosemicarbazonato) complexes. The effects of solvation in water and dimethylsulfoxide (DMSO) are incorporated as a self-consistent reaction field (SCRF) using the integral equation formalism polarisable continuum model (IEFPCM) and are found to be essential for quantitative agreement with an average error in E(calc) of -0.02 V compared to experiment. The bonding and spin densities are examined through the use of Natural Bond Order analysis and the results used to rationalise the calculated and observed reduction potentials. Calculated estimates of pKa values of several copper(II) species are presented and their implications for the mechanisms of transport and trapping within hypoxic cells are considered. Reduction is found to be a prerequisite for protonation of the complexes which suggests their transport in the blood stream as neutral species, and the mechanistic sequence is identified as a sequential electrochemical-chemical (EC) process. The complex equilibria of protonation, reoxidation and dissociation are discussed and the copper(I) diprotonated, cationic complex of diacetyl bis(4-methyl-3-thiosemicarbazonato)copper(II), Cu(I)ATSMH2(+), is identified as a possible candidate for the initial species trapped in hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437173     DOI: 10.1039/b512656h

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  14 in total

1.  Theoretical studies on DNA-photocleavage efficiencies and mechanisms of Ru(II) polypyridyl complexes.

Authors:  Ti-Fang Miao; Shuang Li; Jin-Can Chen; Fang Ma; Kang-Cheng Zheng
Journal:  J Biol Inorg Chem       Date:  2012-08-17       Impact factor: 3.358

2.  Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Authors:  Jason P Holland; Riccardo Ferdani; Carolyn J Anderson; Jason S Lewis
Journal:  PET Clin       Date:  2009-01

3.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

4.  Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

Authors:  Stephen R Bowen; Albert J van der Kogel; Marianne Nordsmark; Søren M Bentzen; Robert Jeraj
Journal:  Nucl Med Biol       Date:  2011-05-05       Impact factor: 2.408

Review 5.  PET imaging of cardiac hypoxia: opportunities and challenges.

Authors:  M G Handley; R A Medina; E Nagel; P J Blower; R Southworth
Journal:  J Mol Cell Cardiol       Date:  2011-07-14       Impact factor: 5.000

Review 6.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

7.  Copper and zinc bis(thiosemicarbazonato) complexes with a fluorescent tag: synthesis, radiolabelling with copper-64, cell uptake and fluorescence studies.

Authors:  SinChun Lim; Katherine A Price; Siow-Feng Chong; Brett M Paterson; Aphrodite Caragounis; Kevin J Barnham; Peter J Crouch; Josephine M Peach; Jonathan R Dilworth; Anthony R White; Paul S Donnelly
Journal:  J Biol Inorg Chem       Date:  2009-09-22       Impact factor: 3.358

Review 8.  Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Authors:  Mark P S Dunphy; Jason S Lewis
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

9.  Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents.

Authors:  Peter J Barnard; Jason P Holland; Simon R Bayly; Thaddeus J Wadas; Carolyn J Anderson; Jonathan R Dilworth
Journal:  Inorg Chem       Date:  2009-08-03       Impact factor: 5.165

10.  CuII (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease.

Authors:  Adam Southon; Kathryn Szostak; Karla M Acevedo; Krista A Dent; Irene Volitakis; Abdel A Belaidi; Kevin J Barnham; Peter J Crouch; Scott Ayton; Paul S Donnelly; Ashley I Bush
Journal:  Br J Pharmacol       Date:  2020-01-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.